367 related articles for article (PubMed ID: 22652521)
1. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis].
Servel AC; Vincenti M; Darras JP; Lalande M; Rodière M; Filleron A
Arch Pediatr; 2012 Jul; 19(7):741-4. PubMed ID: 22652521
[TBL] [Abstract][Full Text] [Related]
2. Acute cholestasis: atypical onset of Kawasaki disease.
Valentini P; Ausili E; Schiavino A; Angelone DF; Focarelli B; De Rosa G; Ranno O
Dig Liver Dis; 2008 Jul; 40(7):582-4. PubMed ID: 18055284
[TBL] [Abstract][Full Text] [Related]
3. Resistant Kawasaki disease treated with anti-CD20.
Sauvaget E; Bonello B; David M; Chabrol B; Dubus JC; Bosdure E
J Pediatr; 2012 May; 160(5):875-6. PubMed ID: 22341587
[TBL] [Abstract][Full Text] [Related]
4. Rare refractory Kawasaki disease in an adolescent boy with cardiac and diffuse coronary artery involvement.
Šileikienė R; Kudzytė J; Jankauskas A; Labanauskas L; Rakauskienė V; Jurkienė N; Kėvalas R
Medicina (Kaunas); 2013; 49(7):341-5. PubMed ID: 24375247
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease.
Lau AC; Duong TT; Ito S; Yeung RS
Arthritis Rheum; 2009 Jul; 60(7):2131-41. PubMed ID: 19565485
[TBL] [Abstract][Full Text] [Related]
6. Hair loss as a sign of Kawasaki disease.
Nabavizadeh SH; Safari M; Amin R
Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):199-200. PubMed ID: 17237574
[TBL] [Abstract][Full Text] [Related]
7. Infliximab as a novel therapy for refractory Kawasaki disease.
Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
[TBL] [Abstract][Full Text] [Related]
8. [Immunoglobulin in suspected Kawasaki disease].
García Soblechero E; Gómez Santos E; Domínguez Quintero ML; González Vila L
An Pediatr (Barc); 2010 Sep; 73(3):151-2. PubMed ID: 20605119
[No Abstract] [Full Text] [Related]
9. Macrophage activation syndrome in Kawasaki disease.
Mukherjee D; Pal P; Kundu R; Niyogi P
Indian Pediatr; 2014 Feb; 51(2):148-9. PubMed ID: 24632699
[TBL] [Abstract][Full Text] [Related]
10. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
De Rosa G; Pardeo M; Rigante D
Eur Rev Med Pharmacol Sci; 2007; 11(5):301-8. PubMed ID: 18074939
[TBL] [Abstract][Full Text] [Related]
11. A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.
Kossiva L; Karanassios E; Papadopoulos G; Karavanaki K
Cardiol Young; 2012 Aug; 22(4):461-5. PubMed ID: 21933460
[TBL] [Abstract][Full Text] [Related]
12. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
Kobayashi T; Inoue Y; Morikawa A
Nihon Rinsho; 2008 Feb; 66(2):332-7. PubMed ID: 18260333
[TBL] [Abstract][Full Text] [Related]
13. Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment.
Lee KY; Oh JH; Han JW; Lee JS; Lee BC
Eur J Pediatr; 2005 Jul; 164(7):451-2. PubMed ID: 15782294
[No Abstract] [Full Text] [Related]
14. Kawasaki disease.
Harnden A; Tulloh R; Burgner D
BMJ; 2014 Sep; 349():g5336. PubMed ID: 25230954
[No Abstract] [Full Text] [Related]
15. Crystalline keratopathy due to intravenous immunoglobulin in a 12-year-old girl with Kawasaki disease.
Viswanathan V; Agashe P; Jain V; Nair AG
J AAPOS; 2016 Oct; 20(5):466-468.e1. PubMed ID: 27667371
[TBL] [Abstract][Full Text] [Related]
16. Kawasaki disease.
Sundel RP
Rheum Dis Clin North Am; 2015; 41(1):63-73, viii. PubMed ID: 25399940
[TBL] [Abstract][Full Text] [Related]
17. Kawasaki disease.
Scuccimarri R
Pediatr Clin North Am; 2012 Apr; 59(2):425-45. PubMed ID: 22560578
[TBL] [Abstract][Full Text] [Related]
18. Hemophagocytic syndrome after Kawasaki disease.
Palazzi DL; McClain KL; Kaplan SL
Pediatr Infect Dis J; 2003 Jul; 22(7):663-6. PubMed ID: 12886898
[TBL] [Abstract][Full Text] [Related]
19. External validation of a scoring system to predict resistance to intravenous immunoglobulin.
Kobayashi T; Inoue Y; Tamura K; Morikawa A; Kobayashi T
J Pediatr; 2007 Apr; 150(4):e37; author reply e38. PubMed ID: 17382098
[No Abstract] [Full Text] [Related]
20. Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation.
Pagnini I; Marino A; Simonini G; Cimaz R
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S170. PubMed ID: 22410254
[No Abstract] [Full Text] [Related]
[Next] [New Search]
